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Mesothelioma is a membrane-based neoplasm that
most commonly arises from the pleura but also from
the pericardium, peritoneum, tunica vaginalis and
ovaries [1]. Generally, malignant pleural mesothe-
lioma predominantly affects males over the age of 50
years and asbestos exposure is the primary cause for 
the development of malignant mesothelioma. Other
potential causes include radiation, viral infection and
exposure to a variety of chemicals. The latent period
between exposure and the onset of symptoms ranges
from 30 to 40 years. Extensive peritoneal infiltration
of malignant mesothelial cells is common in patients
with extensive abdominal disease at autopsy. How-
ever, a search for pancreatic metastasis of the malig-
nant mesothelioma using MEDLINE revealed that
peritoneal carcinomatosis with pancreas infiltration
is seldom found in case reports. To our knowledge,
isolated pancreas metastasis without peritoneal car-
cinomatosis has not been reported before.
CASE PRESENTATION
A 40-year-old male was admitted to hospital with
symptoms of intermittent back pain located in the
right upper region, with radiation to the anterior chest
wall around the intercostals area. He was a heavy
smoker, with a smoking history of three packs per
day for 20 years. He had worked in an asbestos fac-
tory with exposure to asbestos for only 2 months at
the age of 17 years. He then quit that job and became
a public officer. He denied any other systemic disease
or family history. Physical examination revealed clear
bilateral breath sounds. Chest X-ray (Figure 1A) re-
vealed a well-defined soft tissue mass over the right
posterior mediastinum. Chest computed tomography
(CT) (Figure 1B) revealed a 3.7×4.3×6 cm heteroge-
neous contrast-enhanced soft tissue mass that was
localized in the right paraspinal region of T5, with
associated destruction of the T5 vertebral body. Mag-
netic resonance imaging also showed a lobulated soft
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Metastatic malignant mesothelioma of the pleura is uncommon at the time of initial diagnosis. When
metastases are present, the major sites always include regional lymph nodes, the contralateral lung,
liver, adrenal glands and kidneys. Here, we describe an extremely rare case of isolated pancreatic
metastasis of mesothelioma of the pleura in a 40-year-old man who initially presented with epi-
gastric discomfort and hunger pain, which were refractory to medical treatments. The possibility
of pancreatic metastatic lesion should be considered in patients with malignant pleural mesothe-
lioma in the presence of refractory epigastric tenderness.
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tissue mass with isometric T1 signal intensity and
intermediate/high T2 signal intensity in the posterior
mediastinum at the T4–6 level, and it had invaded
into the right aspect of the T4–6 vertebral bodies with
a central low signal intensity component with contrast
enhancement (data not shown).
The posterior mediastinal tumor was excised and
the right lower lobe wedge was removed via thoraco-
tomy on August 2, 2002. The pathologic report revealed
biphasic malignant mesothelioma that contained both
an epithelioid pattern with tubulopapillary prolifera-
tion of epithelioid cells and a sarcomatoid pattern
with interlacing fascicles comprised of spindle cells.
The tumor cells were immunoreactive for vimentin
and cytokeratin (Figure 2). Between August and
December, 2002, the patient underwent four courses of
adjuvant concurrent chemoradiation therapy (CCRT)
with a regimen comprising dacarbazine, cyclophos-
phamide, epirubicin and vincristine. After completion
of the four courses of CCRT, he did not return to the
clinic for further follow-up between 2003 and 2005
and he denied experiencing any symptoms during
this period.
On October 27, 2006, the patient reported clinical
manifestations of hunger pain and abdominal disten-
tion, and a physical examination showed tenderness
over the epigastric area. Initially, a proton pump
inhibitor was prescribed empirically based on the pre-
liminary diagnosis of peptic ulcer disease. However,
after 2 weeks of treatment, the epigastric discomfort
persisted and a palpable mass lesion was found.
Therefore, abdominal CT was performed and revealed
a mass (1.66×9.6×13.3 cm) located over the pancre-
atic head and body, with external compression on 
the superior mesentery artery and the confluence of
splenic vein and superior mesentery vein, without any
evidence of peritoneal carcinomatosis or lymph node
metastasis (Figure 3). Because the serum CA 19-9 level
was elevated to 4,099 U/mL, a pancreatic malignancy
was highly suspected and the patient underwent 
a subtotal pancreatectomy on November 14, 2006.
Microscopically, the pancreatic tumor shared similar
morphological features with the original tumor. Fur-
thermore, the tumor cells were immunohistochemi-
cally positive for cytokeratin, vimentin, calretinin and
cytokeratin 5/6 (CK 5/6) (Figure 4). According to the
overall features, metastatic malignant mesothelioma
was confirmed. After surgery, the patient continued
regular follow-up at the outpatient clinic.
DISCUSSION
Asbestos is widely recognized as a significant risk
factor for the development of mesothelioma. Case-
control studies have estimated that almost 90% of
males with mesothelioma had prior exposure to
asbestos, whereas only 20% of females had prior 
history of exposure [2]. In contrast, cigarette smoking
is not considered to be a risk factor for the development
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Figure 1. (A) Chest X-ray revealed a well-defined soft tissue mass in the right posterior mediastinum (arrow). (B) Chest computed
tomography revealed a 3.7×4.3×6 cm heterogeneous contrast-enhanced soft tissue mass in the right paraspinal region of T5 (arrow).
of mesothelioma [3]. According to a cohort study,
there appears to be a dose-response relationship be-
tween asbestos exposure and mesothelioma, and a
positive correlation between the time between expo-
sure and disease onset with the risk of developing
mesothelioma [4]. However, our patient reported only
2 months of exposure to asbestos without any other
risk factors and the mesothelioma was diagnosed
only 23 years after the exposure to asbestos. Based 
on reviews of the relationship between exposure to
asbestos and mesothelioma, possible co-factors in the
pathogenesis of asbestos-related mesothelioma in-
clude genetic predisposition, diets poor in fruit and
vegetables, viruses, immune impairment and recur-
rent serosal inflammation [5].
Falconieri et al reviewed 171 cases of malignant
mesothelioma at autopsy and discovered that 54% of
patients had distant metastases [6]. The most com-
monly involved organs were the liver (56%), adrenals
Mesothelioma with pancreas metastasis
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Figure 2. Microscopic views of the tumor show: (A) an epithelioid pattern with tubulopapillary structures lined by pleomorphic
epithelioid cells; (B) a sarcomatoid pattern composed of interlacing fascicles of spindle cells (hematoxylin & eosin; original magnification,
200×). Immunohistochemistry revealed the tumor was positive for: (C) vimentin; (D) cytokeratin (original magnification, 400×).
Figure 3. Computed tomography of the abdomen revealed a mass
over the pancreatic head and body (arrows) with external com-
pression on the superior mesentery artery, the confluence of the
splenic vein and the superior mesentery vein, without evidence of
peritoneal carcinomatosis or lymph node metastasis.
(31%) and kidneys (30%). Metastases to the pancreas,
thyroid gland, stomach, bones and cerebrum were
also noted in small numbers (3–6%). In our patient,
malignant mesothelioma was found at the age of 40
and the isolated pancreas tumor shown on abdominal
CT developed 3 years after pleurodectomy and four
courses of CCRT. Because of the greater enhancement
of the normal pancreas, primary or metastatic malig-
nant tumors appear as lower density lesions [7]. These
are often associated with obstruction of the pancreatic
duct. Therefore, we could not differentiate whether
the mass was a primary lesion or metastatic by imaging
studies.
Because of the increased expression of CA 19-9 to
4,099 U/mL and findings of abdominal CT studies,
primary pancreas cancer of adenocarcinoma was ini-
tially proposed. CA 19-9 is a tumor-associated antigen,
which is elevated in pancreatic cancers, cancers of the
upper gastrointestinal tract, ovarian cancer, hepato-
cellular cancer, colorectal cancer, inflammatory con-
ditions of the hepatobiliary system and in thyroid
diseases. Walz et al have emphasized that metaplas-
tic changes in mesothelial cells were responsible for
the production and secretion of CA 19-9 in the lining
and fluid content of splenic cysts [8]. Holtzman et al
presented a case of benign multicystic mesothelioma
of the peritoneum, which was uniquely characterized
by an elevated serum CA 19-9 level and a tissue
biopsy with positive immunostaining for CA 19-9 [9].
Therefore, two possible reasons for the elevated CA
19-9 level in our patient include pancreatic duct
obstruction by the tumor and abnormal secretion 
of CA 19-9 from mesothelial cells.
The pathological differentiation between metastatic
mesothelioma in the pancreas and pancreatic primary
adenocarcinoma is challenging. Electron microscopy
was considered a useful diagnostic tool for the recog-
nition of malignant mesotheliomas. However, in this
case, we consider the immunohistochemistry (IHC)
panel to be as valuable, convenient and rapid as elec-
tron microscopy for the establishment of a definitive
diagnosis of malignant mesothelioma [10]. In addition
to markers that support a diagnosis of adenocarci-
noma, including CA 19-9 and carcinoembryonic anti-
gen, there are now a number of commercially available
antibodies that are reliable markers for mesothelial
differentiation including calretinin, cytokeratin 5/6
and Wilms’ tumor-1 antigen. There is no single marker
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Figure 4. The pancreatic tumor had tubulopapillary structures in epithelioid cells, which were similar to the original mesothelioma
(hematoxylin & eosin; original magnification, 200×). The inserted figures show immunoreactivity for: (A) vimentin; and (B) cytokeratin
(original magnification, 400×).
that has sufficiently high sensitivity and specificity for
malignant mesothelioma. In our patient, the primary
lesion was diagnosed as a malignant pleural mixed
mesothelioma based on histological and IHC marker
findings. The findings from the IHC markers are con-
sistent with the diagnosis of metastatic mesothelioma
of the pancreas.
In conclusion, local control of pleural mesothelioma
improves the survival rate. Thus, an increasing num-
ber of patients presenting with spread of the disease
to unusual sites is much more likely. The possibility
of pancreatic metastatic lesions should be considered
in patients with malignant pleural mesothelioma in
the presence of epigastric discomfort.
REFERENCES
1. Hammar SP. Macroscopic, histologic, histochemical,
immunohistochemical, and ultrastructural features of
mesothelioma. Ultrastruct Pathol 2006;30:3–17.
2. Spirtas R, Heineman EF, Bernstein L, et al. Malignant
mesothelioma: attributable risk of asbestos exposure.
Occup Environ Med 1994;51:804–11.
3. Muscat JE, Wynder EL. Cigarette smoking, asbestos
exposure, and malignant mesothelioma. Cancer Res
1991;51:2263–7.
4. Pira E, Pelucchi C, Buffoni L, et al. Cancer mortality in
a cohort of asbestos textile workers. Br J Cancer 2005;
92:580–6.
5. Bianchi C, Bianchi T. Malignant mesothelioma: global
incidence and relationship with asbestos. Ind Health
2007;45:379–87.
6. Falconieri G, Grandi G, DiBonito L, et al. Intracranial
metastases from malignant pleural mesothelioma.
Report of three autopsy cases and review of the litera-
ture. Arch Pathol Lab Med 1991;115:591–5.
7. Horton KM, Fishman EK. Adenocarcinoma of the 
pancreas: CT imaging. Radiol Clin North Am 2002;40:
1263–72.
8. Walz MK, Metz KA, Sastry M, et al. Benign mesothelial
splenic cyst may cause high serum concentration of
CA 19-9. Eur J Surg 1994;160:389–91.
9. Holtzman RN, Heymann AD, Bordone F, et al. Carbo-
hydrate antigen 19-9 and carcinoembryonic antigen
immunostaining in benign multicystic mesothelioma
of the peritoneum. Arch Pathol Lab Med 2001;125:944–7.
10. Abutaily AS, Addis BJ, Roche WR. Immunohisto-
chemistry in the distinction between malignant meso-
thelioma and pulmonary adenocarcinoma: a critical
evaluation of new antibodies. J Clin Pathol 2002;55:662–8.
Mesothelioma with pancreas metastasis
Kaohsiung J Med Sci July 2009 • Vol 25 • No 7 399
400 Kaohsiung J Med Sci July 2009 • Vol 25 • No 7
收文日期：98 年 1 月 14 日
接受刊載：98 年 3 月 3 日
通訊作者：陳煌麒醫師
高雄市立小港醫院內科
高雄市小港區山明路 482號
惡性肋膜間皮瘤併發單獨性的胰臟轉移 — 
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轉移的惡性肋膜間皮瘤在一開始診斷時並不常見。當轉移發生時，主要轉移的部位大
多在局部的淋巴結、對側肺臟、肝臟、腎上腺和腎臟。我們在此描述一位四十歲男性
剛開始以上腹部不適及飢餓造成疼痛來表現，且對藥物治療反應不佳，後被診斷為惡
性肋膜間皮瘤併發單獨性胰臟轉移的罕見病例。當難治的上腹部疼痛發生在惡性肋膜
間皮瘤的病人時，胰臟轉移的可能性仍然是必須列入考慮的。
關鍵詞：腹痛，惡性間皮瘤，轉移，胰臟，肋膜
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